Filing Details

Accession Number:
0001209191-19-058413
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-29 14:40:51
Reporting Period:
2019-11-26
Accepted Time:
2019-11-29 14:40:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649904 Rhythm Pharmaceuticals Inc. RYTM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1473930 Todd Foley C/O Mpm Asset Management
450 Kendall Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-26 74,225 $23.31 2,570,355 No 4 S Indirect See Footnote
Common Stock Disposition 2019-11-27 34,960 $22.91 2,535,395 No 4 S Indirect See Footnote
Common Stock Disposition 2019-11-29 18,359 $22.67 2,517,036 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. Shares were sold as follows: 71,449 by BV V and 2,776 by AM BV5.
  3. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $22.71 to $23.56. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. Shares are held as follows: 2,474,236 by BV V and 96,119 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  5. Shares were sold as follows: 33,653 by BV V and 1,307 by AM BV5.
  6. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $22.41 to $23.385. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  7. Shares are held as follows: 2,440,583 by BV V and 94,812 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  8. Shares were sold as follows: 17,672 by BV V and 687 by AM BV5.
  9. The price in Column 4 is a weighted average sale price. The prices actually received ranged from $22.36 to $22.95. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  10. Shares are held as follows: 2,422,911 by BV V and 94,125 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.